WORK Medical Technology Group is trading 5.4% down at $2.10, with no clearly reported company-specific catalyst identified for September 2, 2026.

  • The latest material disclosure was an August 24 filing describing a $2.125 million private placement that could create dilution.
  • Available evidence does not directly connect the placement to today’s decline.
  • The broader healthcare sector and major U.S. indexes are higher, so market strength does not explain the drop.